Quantifying protocol evaluation for autonomous collision avoidance

Collision avoidance protocols such as COLREGS are written primarily for human operators resulting in a rule set that is open to some interpretation, difficult to quantify, and challenging to evaluate. Increasing use of autonomous control of vehicles emphasizes the need to more uniformly establish entry and exit criteria for collision avoidance rules, adopt a means to quantitatively evaluate performance, and establish a “road test” for autonomous marine vehicle collision avoidance. This paper presents a means to quantify and subsequently evaluate the otherwise subjective nature of COLREGS thus providing a path toward standardized evaluation and certification of protocol-constrained collision avoidance systems based on admiralty case law and on-water experience. Notional algorithms are presented for evaluation of COLREGS collision avoidance rules to include overtaking, head-on, crossing, give-way, and stand-on rules as well as applicable entry criteria. These rules complement and enable an autonomous collision avoidance road test as a first iteration of algorithm certification prior to vessels operating in human-present environments. Additional COLREGS rules are discussed for future development. Both real-time and post-mission protocol evaluation tools are introduced. While the motivation of these techniques applies to improvement of autonomous marine collision avoidance, the concepts for protocol evaluation and certification extend naturally to human-operated vessels. Evaluation of protocols governing other physical domains may also benefit from adapting these techniques to their cases. Keywords: COLREGS; Autonomous collision avoidance; Human–robot collaboration; Marine navigatio

Quantifying protocol evaluation for autonomous collision avoidance

Collision avoidance protocols such as COLREGS are written primarily for human operators resulting in a rule set that is open to some interpretation, difficult to quantify, and challenging to evaluate. Increasing use of autonomous control of vehicles emphasizes the need to more uniformly establish entry and exit criteria for collision avoidance rules, adopt a means to quantitatively evaluate performance, and establish a “road test” for autonomous marine vehicle collision avoidance. This paper presents a means to quantify and subsequently evaluate the otherwise subjective nature of COLREGS thus providing a path toward standardized evaluation and certification of protocol-constrained collision avoidance systems based on admiralty case law and on-water experience. Notional algorithms are presented for evaluation of COLREGS collision avoidance rules to include overtaking, head-on, crossing, give-way, and stand-on rules as well as applicable entry criteria. These rules complement and enable an autonomous collision avoidance road test as a first iteration of algorithm certification prior to vessels operating in human-present environments. Additional COLREGS rules are discussed for future development. Both real-time and post-mission protocol evaluation tools are introduced. While the motivation of these techniques applies to improvement of autonomous marine collision avoidance, the concepts for protocol evaluation and certification extend naturally to human-operated vessels. Evaluation of protocols governing other physical domains may also benefit from adapting these techniques to their cases. Keywords: COLREGS; Autonomous collision avoidance; Human–robot collaboration; Marine navigatio

The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors

The management of brain-dead organ donors is complex. The use of inotropic agents and replacement of depleted hormones (hormonal replacement therapy) is crucial for successful multiple organ procurement, yet the optimal hormonal replacement has not been identified, and the statistical adjustment to determine the best selection is not trivial. Traditional pair-wise comparisons between every pair of treatments, and multiple comparisons to all (MCA), are statistically conservative. Hsu’s multiple comparisons with the best (MCB)-adapted from the Dunnett’s multiple comparisons with control (MCC)-has been used for selecting the best treatment based on continuous variables. We selected the best hormonal replacement modality for successful multiple organ procurement using a two-step approach. First, we estimated the predicted margins by constructing generalized linear models (GLM) or generalized linear mixed models (GLMM), and then we applied the multiple comparison methods to identify the best hormonal replacement modality given that the testing of hormonal replacement modalities is independent. Based on 10-year data from the United Network for Organ Sharing (UNOS), among 16 hormonal replacement modalities, and using the 95% simultaneous confidence intervals, we found that the combination of thyroid hormone, a corticosteroid, antidiuretic hormone, and insulin was the best modality for multiple organ procurement for transplantation

Challenges and opportunities of lifelog technologies: a literature review and critical analysis

In a lifelog, data from various sources are combined to form a record from which one can retrieve information about oneself and the environment in which one is situated. It could be considered similar to an automated biography. Lifelog technology is still at an early stage of development. However, the history of lifelogs so far shows a clear academic, corporate and governmental interest. Therefore, a thorough inquiry into the ethical aspects of lifelogs could prove beneficial to the responsible development of this field. This article maps the main ethically relevant challenges and opportunities associated with the further development of lifelog technologies as discussed in the scholarly literature. By identifying challenges and opportunities in the current debate, we were able to identify other challenges and opportunities left unmentioned. Some of these challenges are partly explained by a blind spot in the current debate. Whilst the current debate focuses mainly on lifelogs held by individuals, lifelogs held by governmental institutions and corporations pose idiosyncratic ethical concerns as well. We have provided a brief taxonomy of lifelog technology to show the variety in uses for lifelogs. In addition, we provided a general approach to alleviate the ethical challenges identified in the critical analysis

B-meson production at forward and backward rapidity in p+p and Cu + Au collisions at √sNN=200 GeV

The fraction of J/psi mesons which come from B-meson decay, F-B -> J/psi is measured for J/psi rapidity 1.2 0 in p + p and Cu+Au collisions at root s(NN) = 200 GeV with the PHENIX detector. The extracted fraction is F-B -> J/psi = 0.025 +/- 0.006 (stat) +/- 0.010(syst) for p + p collisions. For Cu+Au collisions, F-B -> J/psi is 0.094 +/- 0.028(stat) +/- 0.037(syst) in the Au-going direction (-2.2 <y <-1.2) and 0.089 +/- 0.026(stat) +/- 0.040(syst) in the Cu-going direction (1.2 <y <2.2). The nuclear modification factor, R-CuAu,of B mesons in Cu+Au collisions is consistent with binary scaling of measured yields in p + p at both forward and backward rapidity.Peer reviewe

A review of contemporary work on the ethics of ambient assisted living technologies for people with dementia

Ambient assisted living (AAL) technologies can provide assistance and support to persons with dementia. They might allow them the possibility of living at home for longer whilst maintaining their comfort and security as well as offering a way towards reducing the huge economic and personal costs forecast as the incidence of dementia increases worldwide over coming decades. However, the development, introduction and use of AAL technologies also trigger serious ethical issues. This paper is a systematic literature review of the on-going scholarly debate about these issues. More specifically, we look at the ethical issues involved in research and development (R&D), clinical experimentation, and clinical application of AAL technologies for people with dementia and related stakeholders. In the discussion we focus on: 1) the value of the goals of AAL technologies, 2) the special vulnerability of persons with dementia in their private homes, 3) the complex question of informed consent for the usage of AAL technologies

The convergence of virtual reality and social networks: threats to privacy and autonomy

The rapid evolution of information, communication and entertainment technologies will transform the lives of citizens and ultimately transform society. This paper focuses on ethical issues associated with the likely convergence of virtual realities (VR) and social networks (SNs), hereafter VRSNs. We examine a scenario in which a significant segment of the world’s population has a presence in a VRSN. Given the pace of technological development and the popularity of these new forms of social interaction, this scenario is plausible. However, it brings with it ethical problems. Two central ethical issues are addressed: those of privacy and those of autonomy. VRSNs pose threats to both privacy and autonomy. The threats to privacy can be broadly categorized as threats to informational privacy, threats to physical privacy, and threats to associational privacy. Each of these threats is further subdivided. The threats to autonomy can be broadly categorized as threats to freedom, to knowledge and to authenticity. Again, these three threats are divided into subcategories. Having categorized the main threats posed by VRSNs, a number of recommendations are provided so that policy-makers, developers, and users can make the best possible use of VRSNs

Ethics of AAL for people with dementia

Ambient assisted living (AAL) technologies can provide assistance and support to vulnerable persons, including those who suffer from dementia. They might allow these persons the possibility of living at home for longer whilst still maintaining their comfort, safety and security. However, the development, introduction and use of AAL technologies also trigger serious ethical issues. This presentation will provide an overview of the ongoing scholarly debate about these issues. We address the question of what ethical issues are involved in the various stages of research and development, clinical experimentation, and clinical application of AAL technologies for people with dementia (PwD) and other related stakeholders? The presentation will focus specifically on the value of the goals of AAL for persons with dementi